Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient

Annals of Surgery

Volumn 255, Issue 2, 2012, Pages 287-293

  Dorman, Robert B ^a   Serrot, Federico J ^a   Miller, Christopher J ^b   Slusarek, Bridget M ^a   Sampson, Barbara K ^a   Buchwald, Henry ^a   Leslie, Daniel B ^a   Bantle, John P ^b   Ikramuddin, Sayeed ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C;

ADULT; AGE; ARTICLE; BARIATRIC SURGERY; BODY MASS; BODY WEIGHT; COMPARATIVE EFFECTIVENESS; DIABETES CONTROL; DUODENUM SWITCH; FEMALE; GASTRIC BANDING; HEMOGLOBIN BLOOD LEVEL; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; SEX DIFFERENCE; STOMACH BYPASS; SURGICAL PATIENT; WEIGHT REDUCTION;

BARIATRIC SURGERY; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GASTROPLASTY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84855856266     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318232b033     Document Type: Article

References (22)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053. (Pubitemid 38579764)
2. Shai I, Jiang R,Manson JE, et al. Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care. 2006;29:1585-1590. (Pubitemid 44127585)
3. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery a systemic review and meta-analysis. JAMA. 2004;292:1724-1737. (Pubitemid 39346675)
4. Sj̈ostr̈om L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693. (Pubitemid 39665322)
5. Schauer PR,Burguera B, Ikramuddin S, et al. Effect of laparoscopicRoux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467-484.
6. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122: 248-256.e5.
7. MacDonald KG, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997;1:213-220. (Pubitemid 127432762)
8. Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515-529.
9. Ikramuddin S, Kendrick ML, Kellogg TA, et al. Open and laparoscopic Rouxen-Y gastric bypass: our techniques. J Gastrointest Surg. 2007;11:217-228.
10. Buchwald H,Kellogg TA, Leslie DB, et al. Duodenal switch operative mortality and morbidity are not impacted by body mass index. Ann Surg. 2008;248: 541-548.
11. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized control trial. JAMA. 2008;299:316-323. (Pubitemid 351159368)
12. Campos GM, Rabl C, Roll GR, et al. Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass vs banding: results of a 2-cohort pair-matched study. Arch Surg. 2011;146:149-155.
13. Prachand VN, Davee RT, Alverdy JC. Duodenal switch provides superior weight loss in the super-obese (BMI or = 50 kg/m2) compared with the gastric bypass. Ann Surg. 2006;244:611-619.
14. Ferrannini E, Mingrone G. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care. 2009;32:514-520.
15. Grevo AV, Mingrone G, Giancaterini A, et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes. 2002;51:7-18.
16. Boza C, Gamboa C, Awruch D, et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding: five years of follow-up. Surg Obes Relat Dis. 2010;6:470-476.
17. Martin LF, Smits GJ, GreensteinRJ. Treatingmorbid obesity with laparoscopic adjustable gastric banding. Am J Surg. 2007;194:333-348.
18. Bertoni AG, Clark JM, Feeney P, et al. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. J Diabetes Complications. 2008;22:1-9.
19. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339-352.
20. Dixon JB, Dixon AF, O'Brien PE. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabet Med. 2003;20: 127-134. (Pubitemid 36269654)
21. Harris MI, Klein RE, Welborn TA, et al. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992;15: 815-819.
22. Philippe MF, Benabadji S, Barbot-Trystram L, et al. Pancreatic volume and endocrine and exocrine functions in patients with diabetes. Pancreas. 2011;40:359-363.